X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (9) 9
humans (8) 8
cancer (7) 7
oncology (7) 7
lymphomas (6) 6
adult (5) 5
chemotherapy (5) 5
childhood-cancer (5) 5
disease (5) 5
female (5) 5
incidence (5) 5
risk factors (5) 5
2nd malignancy (4) 4
confidence intervals (4) 4
hodgkin lymphoma (4) 4
lymphoma (4) 4
male (4) 4
middle aged (4) 4
radiation therapy (4) 4
survivors (4) 4
young adult (4) 4
abridged index medicus (3) 3
age (3) 3
breast cancer (3) 3
breast-cancer (3) 3
care and treatment (3) 3
follow-up studies (3) 3
health risk assessment (3) 3
hematology (3) 3
hodgkin disease - drug therapy (3) 3
hodgkin disease - radiotherapy (3) 3
hodgkin's disease (3) 3
leukemia (3) 3
neoplasms, second primary - epidemiology (3) 3
netherlands - epidemiology (3) 3
patients (3) 3
procarbazine (3) 3
radiotherapy (3) 3
research (3) 3
risk (3) 3
stomach-cancer (3) 3
adolescent (2) 2
age factors (2) 2
animals (2) 2
antineoplastic agents, alkylating - adverse effects (2) 2
cancer therapies (2) 2
case-control studies (2) 2
collaborative british cohort (2) 2
colorectal carcinoma (2) 2
follow-up (2) 2
gastrointestinal cancer (2) 2
health aspects (2) 2
health risks (2) 2
lung-cancer (2) 2
menopause (2) 2
mice (2) 2
neoplasms (2) 2
neoplasms, radiation-induced - epidemiology (2) 2
neoplasms, radiation-induced - etiology (2) 2
neoplasms, second primary - etiology (2) 2
population (2) 2
radiation (2) 2
survival (2) 2
trends (2) 2
tumors (2) 2
young-women (2) 2
2nd malignant neoplasms (1) 1
5-year survivors (1) 1
abstracts (1) 1
activation (1) 1
adaptor proteins, signal transducing - genetics (1) 1
adenosine-deaminase (1) 1
adult cancer (1) 1
advanced basic science (1) 1
alkylating agents (1) 1
alkylation (1) 1
analysis (1) 1
antigens, cd34 - metabolism (1) 1
antimitotic agents (1) 1
antineoplastic agents (1) 1
antineoplastic agents - administration & dosage (1) 1
antineoplastic agents - adverse effects (1) 1
antineoplastic agents, alkylating - administration & dosage (1) 1
antineoplastic agents, alkylating - therapeutic use (1) 1
antineoplastic combined chemotherapy protocols - therapeutic use (1) 1
anxiety (1) 1
article (1) 1
atomic-bomb survivors (1) 1
b-cell lymphoma (1) 1
biological sciences (1) 1
bleomycin - therapeutic use (1) 1
bone marrow cells - cytology (1) 1
breast - drug effects (1) 1
breast - radiation effects (1) 1
breast carcinogenesis (1) 1
breast neoplasms - etiology (1) 1
cancer survivors (1) 1
carcinoma, intraductal, noninfiltrating - etiology (1) 1
cell differentiation - genetics (1) 1
cell line (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 2015, Volume 373, Issue 26, pp. 2499 - 2511
Journal Article
British journal of cancer, ISSN 0007-0920, 2017, Volume 117, Issue 3, pp. 306 - 314
Hodgkin lymphoma (HL) survivors are at increased risk of second malignancies, but few studies have assessed colorectal cancer (CRC) risk after HL treatment. We... 
colorectal cancer | ATOMIC-BOMB SURVIVORS | LONG-TERM RISKS | COLLABORATIVE BRITISH COHORT | chemotherapy | STOMACH-CANCER | procarbazine | second malignant neoplasm | long-term complications | LUNG-CANCER | CHILDHOOD-CANCER | GASTROINTESTINAL CANCER | ONCOLOGY | radiation therapy | DISEASE | 2ND MALIGNANCY | Hodgkin lymphoma | Procarbazine - administration & dosage | Doxorubicin - therapeutic use | Follow-Up Studies | Humans | Middle Aged | Neoplasms, Radiation-Induced - etiology | Netherlands - epidemiology | Male | Antineoplastic Agents - administration & dosage | Vinblastine - therapeutic use | Mechlorethamine - therapeutic use | Young Adult | Hodgkin Disease - radiotherapy | Colorectal Neoplasms - etiology | Bleomycin - therapeutic use | Hodgkin Disease - drug therapy | Adult | Female | Colon | Colorectal Neoplasms - epidemiology | Risk Factors | Survivors | Neoplasms, Second Primary - epidemiology | Neoplasms, Second Primary - etiology | Procarbazine - therapeutic use | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Rectum | Vincristine - therapeutic use | Diaphragm | Neoplasms, Radiation-Induced - epidemiology | Prednisone - therapeutic use | Procarbazine | Colorectal carcinoma | Colorectal cancer | Radiation | Health risks | Radiation therapy | Regression analysis | Cancer therapies | Patients | Lymphoma | Incidence | Confidence intervals | Chemotherapy | Colon cancer | Irradiation | Lymphomas | Hodgkin's disease | Cancer | Index Medicus | Clinical Study
Journal Article
International Journal of Radiation Oncology, Biology, Physics, ISSN 0360-3016, 11/2017, Volume 99, Issue 4, pp. 843 - 853
Young women treated with chest radiation therapy (RT) for Hodgkin lymphoma (HL) experience a strongly increased risk of breast cancer (BC). It is unknown... 
CHILDHOOD-CANCER | ONCOLOGY | DISEASE | REPLACEMENT THERAPY | EARLY MENOPAUSE | ESTROGEN PLUS PROGESTIN | COLLABORATIVE REANALYSIS | YOUNG-WOMEN | SURVIVORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | 2ND MALIGNANCY | CHEMOTHERAPY | Confidence Intervals | Humans | Middle Aged | Neoplasms, Radiation-Induced - etiology | Breast Neoplasms - etiology | Hormone Replacement Therapy - adverse effects | Case-Control Studies | Young Adult | Gonadal Steroid Hormones - physiology | Hodgkin Disease - radiotherapy | Menopause, Premature | Netherlands | Time Factors | Antineoplastic Agents - adverse effects | Hodgkin Disease - drug therapy | Adult | Female | Carcinoma, Intraductal, Noninfiltrating - etiology | Breast - radiation effects | Radiotherapy Dosage | Risk Factors | Gonadal Steroid Hormones - pharmacology | Survivors | Ovary - physiology | Antineoplastic Agents, Alkylating - therapeutic use | Procarbazine - adverse effects | Breast - drug effects | Antineoplastic Agents, Alkylating - adverse effects | Dose-Response Relationship, Radiation | Antimitotic agents | Care and treatment | Radiation | Breast cancer | Lymphomas | Plants | Hormones | Radiotherapy | Antineoplastic agents | Health aspects | Risk factors | Cancer | Hormone therapy | Menopause | Oncology, Experimental | Medical records | Mammography | Research | Index Medicus
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 02/2017, Volume 35, Issue 4, pp. 40 - 40
Conference Proceeding
The New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 26, pp. 2499 - 2511
Despite efforts to reduce the incidence of second cancer, the risk was not lower among 5-year survivors of Hodgkin's lymphoma in the Netherlands treated... 
Procarbazine | Chemotherapy | Menopause | Lymphomas | Breast cancer | Radiation therapy | Health risk assessment | Lymphoma | Cancer therapies | Patients | Age | Cancer | Population | Trends | Tumors
Journal Article
New England Journal of Medicine, ISSN 0028-4793, 12/2015, Volume 373, Issue 26, pp. 2499 - 2511
BACKGROUND Survivors of Hodgkin's lymphoma are at increased risk for treatment-related subsequent malignant neoplasms. The effect of less toxic treatments,... 
Journal Article
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 05/2014, Volume 32, Issue 15, pp. 9517 - 9517
Conference Proceeding
Clinical and Translational Radiation Oncology, ISSN 2405-6308, 12/2017, Volume 7, pp. 20 - 27
An increased risk of breast cancer following radiotherapy for Hodgkin lymphoma (HL) has now been robustly established. In order to estimate the dose–response... 
Retrospective dosimetry | Breast carcinogenesis | Hodgkin lymphoma
Journal Article
ISSN 2405-6308, 2017
Abstract Background An increased risk of breast cancer following radiotherapy for Hodgkin lymphoma (HL) has now been robustly established. In order to estimate... 
Journal Article
Journal Article
by de Vette, Ivar and Lombardo, Angelo and Berkhout, Ben and Vervoordeldonk, Margriet and Dekkers, Johanna F and Kruisselbrink, Evelien and Vonk, Annelotte M and de Jonge, Hugo R and de Winter, Karin M and de Groot, – and Janssens, Hettie M and Bronsveld, Inez and Nieuwenhuis, Edward E.S and Houwen, Roderick H.J and Vleggaar, Frank P and Escher, Hankje C and Clevers, Hans and van der Ent, Cornelis K and Buckland, Karen and Rivat, Christine and Himoudi, Nourredine and Gilmour, Kimberly and Booth, Claire and Cornetta, Kenneth and Kohn, Don B and Carbonaro, Denise and Paruzynski, Anna and Schmidt, Manfred and Thrasher, Adrian J and Schaffer, David and Hwang, Tae-Ho and Zinn, E and Khaychuk, V and Sarkar, D and Carvalho, L and Pacouret, S and Morris, H and Plovie, E and van Gent, Michiel and Gram, Anna and Boer, Ingrid and Horst, Danielle and Zaldumbide, Arnaud and Hoeben, Rob and Wiertz, Emmanuel and Maring, J and Smits, AM and Ouyang, Hong and Lin, Ying and Wang, Yujuan and Cai, Humim and Li, Gen and Patel, Sherrina and Zhu, Jie and Lin, Danni and Wen, Cindy and Zhu, Jin and Tsaalbi-Shtylik, Anastasia and Martín-Pardillos, Ana and Ferras, Cristina and Verspuy, Johan and Speksnijder, Ewoud and Jansen, Jacob and Peng, Kah Whye and Federspiel, Mark and Naik, Shruthi and Ruiz, Autumn and Lacy, Martha and Dispenzieri, Angela and O'Donovan, Liz and Arzumanov, Andrey A and Rahim, A.A and Burke, D.G and Buckley, S.M and Cullen, E and Mukherji, S and Mills, K and Sirka, E and Herbert, B and Karlsson, S and Hughes, D.A and Mehta, A.B and Howe, S.J and Heales, S and Cooper, J.D and Cheng, S.H and van Til, Niek P and Liang, Q and Stok, M and Wagemaker, G and Reiss, Ulrike M and Tuddenham, Edward G.D and Nienhuis, Arthur W and Davidoff, Andrew M and Meneghini, V and Lattanzi, A and Tiradani, L and Bravo, G and Morena, F and Martino, S and ...
Human Gene Therapy, ISSN 1043-0342, 11/2014, Volume 25, Issue 11, pp. A1 - A121
Journal Article
Human Immunology, ISSN 0198-8859, 1987, Volume 18, Issue 4, pp. 265 - 276
Polymorphism of the HLA-D/DR region has been defined by serologic and cellular methods. Additionally, protein and DNA analyses not only confirmed and refined... 
Haplotypes | Cell Line | Nucleic Acid Hybridization | HLA-D Antigens - genetics | Polymorphism, Restriction Fragment Length | DNA - analysis | Humans | HLA-DR Antigens - genetics | Polymorphism, Genetic | Index Medicus
Journal Article
19.